Bank of New York Mellon’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
18,570
+1,419
+8% +$22.5K ﹤0.01% 4045
2026
Q1
$276K Sell
17,151
-947
-5% -$16.5K ﹤0.01% 3893
2025
Q4
$334K Buy
18,098
+1,510
+9% +$27.6K ﹤0.01% 3809
2025
Q3
$299K Sell
16,588
-791
-5% -$14.6K ﹤0.01% 3859
2025
Q2
$337K Sell
17,379
-978
-5% -$18.4K ﹤0.01% 3744
2025
Q1
$285K Buy
18,357
+2,370
+15% +$42.4K ﹤0.01% 3726
2024
Q4
$285K Sell
15,987
-230
-1% -$3.96K ﹤0.01% 3811
2024
Q3
$293K Sell
16,217
-5,793
-26% -$106K ﹤0.01% 3775
2024
Q2
$342K Buy
+22,010
New +$364K ﹤0.01% 3759

Other funds holding MDWD

Bank of New York Mellon's MDWD Position: Q2 2026 in Review

Bank of New York Mellon increased its MediWound (MDWD) stake by 8.3% in Q2 2026, buying an estimated $22.5K and bringing the position to 18,570 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

Bank of New York Mellon first reported a position in MDWD in Q2 2024 and has held it in 9 quarters since. The position peaked at $342K in Q2 2024. 41 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Bank of New York Mellon held 18,570 shares of MediWound worth $273K as of Q2 2026.
  • Bank of New York Mellon bought 1,419 MediWound shares in Q2 2026, an estimated $22.5K.
  • MediWound made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4045 holding.
  • Bank of New York Mellon first reported a position in MediWound in Q2 2024 and has held it in 9 quarters since.
  • Bank of New York Mellon's MediWound position peaked at $342K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.